Targeted methylation sequencing technology has been employed to assess the methylation status of specific CpG sites, including those in the differentially methylated region of HIPK3 in 235 recruited RA patients.[51] The results indicate that HIPK3 can serve as a new diagnostic marker for RA. The gene discussed is HIPK3; the disease is rheumatoid arthritis.